MedTrace Logo

A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype

NCT04981275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2023-11-01

No results posted yet for this study

Summary

The purpose of this research study is to explore the relationship between the gut microbiome and hormone levels in women diagnosed with PCOS and determine whether there are differences in the gut microbiome between women with PCOS and women without PCOS.

Consented, enrolled participants will complete a health questionnaire, complete a fasted blood draw at a local laboratory, and provide a stool, saliva, and vaginal swab sample for comprehensive biomarkers, hormones, metagenomics, and metabolomics analysis.

Conditions

  • Polycystic Ovary Syndrome

Interventions

OTHER

No intervention study

This observational study will only collect data, not provide any intervention to participants.

Sponsors & Collaborators

  • University of Maryland, Baltimore

    collaborator OTHER

  • Onegevity Health

    lead INDUSTRY

Principal Investigators

  • Chris D'Adamo, PhD · University of Maryland

  • Chris Mason, PhD · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-19
Primary Completion
2022-01-11
Completion
2023-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04981275 on ClinicalTrials.gov